I am JM. I write badly. I am basically an ignorant with internet connection. Thank you for your time. Sorry for wasting It. Your welcome for amusing you.

FOR QUARTER ENDING : 30-JUN-25 Source link

We have a special episode for today's Cryptid Creator Corner as Jimmy chats with both J.M. Brandt and Don Cardenas about their respective Kickstarter projects....

Create beautiful masks that fulfill your clients' requests.

Price: (as of - Details) Whether you step into the office or step out on the weekend, JM Haggar dress pants, fit your needs perfectly. You'll love the look and classic color options as much as you'll appreciate the feel of the premium fabric offered in multiple fits. Package Dimensions ‏ : ‎ 16.85 x 10.79 x 2.64 inches; 1.54 Pounds Department ‏ : ‎ mens Date First Available ‏ : ‎ May 8, 2025 Manufacturer ‏ : ‎ J.M. Haggar ASIN ‏ : ‎ B0F7WFMZBN Best Sellers Rank: #20,155 in Clothing, Shoes & Jewelry (See Top 100 in Clothing, Shoes & Jewelry) #45 in Men's Dress Pants …

YouTube video by Rabbi Jonathan Kligler - Topic

YouTube video by Mercury Studios

Background Adenosquamous carcinoma of the pancreas (ASCP) is a rare and aggressive subtype of pancreatic cancer. Compared with other pancreatic tumors, ASCP has a notably poorer prognosis and shorter survival rates. The optimal therapeutic approaches to ASCP have yet to be defined. Methods This retrospective, multicenter European study included all consecutive patients who underwent elective pancreatic surgery for ASCP at participating centers between 2010 and 2024. The inclusion criteria encompassed all patients who underwent scheduled surgery for ASCP during the study period. The exclusion criteria ruled out patients without a confirmed pathologic diagnosis of ASCP, those who did not undergo surgery, and patients with extra-pancreatic disease. Results The study analyzed 194 patients from 29 hospitals in 11 European countries. The overall survival rates were 56.2% at 1 year, 26.3% at 3 years, and 9.8% at 5 years. The disease-free survival rates at the same intervals were 36.6%, 16.5%, and 6.7%, respectively. In the multivariate analysis, significant associations with shorter survival were R2 resections, lymphatic stromal invasion, T4 stage, no adjuvant chemotherapy, and recurrence. Conclusions Patients who undergo resection for ASCP experience very low 5-year survival rates (10%). It is advisable to avoid resecting T4 tumors in patients with significant comorbidities or R2 resections. Additionally, failure to provide adjuvant chemotherapy, often due to severe postoperative complications, further deteriorates the prognosis.